Welcome to DFJ InCube Ventures

DFJ InCube Ventures (DIV) is a venture capital firm focused on innovative medical technologies that can significantly improve clinical outcomes. The fund is led by Mir Imran, one of the world's most successful medical device innovators. Mir is joined by Andrew Farquharson and Wayne Roe, proven entrepreneurs and investors in their own right. All three Managing Directors have built world-dominant companies in therapeutics, reimbursement and research. The DIV team has worked together for years, building a track record of inventing and commercializing over 20 healthcare technologies.

You can learn more about the team in the "About" Section and we invite you to browse our Media and News Articles, or to visit the InCube Labs website: www.incubelabs.com  


Latest Content
Check out Videos of InCube Labs CEO Mir Imran talking about company formation, and development ideas in our Media section.

  latest news and events
Jan 09, 2009
In a panel session on medical electronics Thursday morning (Jan. 8th) at the Consumer Electronics Show in Las Vegas, Howard Jay Chizek, a professor of electrical engineering at the University of Washington, posed—as one futuristic possibility in medicine—a scenario in which one doctor simultaneously directs robots doing several routine surgical procedures on different patients, without even washing his hands between operations.

These and other medical advances are within reach, according to the members of a panel called "Your Robot Will See You Now," except for one overshadowing issue: who pays and how.

Sep 02, 2008
In the foothills of the Valley, Mir Imran personifies the cusp between high-tech and biotech. At 52, Mir has founded over 20 medical device companies, holds over 200 patents and is perhaps best known for his pioneering contributions to the first FDA- approved Automatic Implantable Cardioverter Defibrillator.
Feb 20, 2008
Parallel entrepreneur Mir Imran, CEO of InCube Labs, has launched twenty companies - at times simultaneously. He shares his solutions-focused expertise and identifies the vitality and growth of the biomedical healthcare vertical.